9.30am - 10.00am Registration and morning coffee

10.00am - 10.10am

Welcome and Official Opening
Glenn Cross, Chief Executive Officer, AusBiotech

10.10am - 10.30am

KEYNOTE: Pharma 2030 - opportunities for biotech companies, business models and trends

Jia Zhou
, Director, Global Strategy Group, KPMG Hong Kong

10.30am - 11.15am

Company Spotlight Presentations

- Dr Brad Walsh, Chief Executive Officer, Minomic International

- Mark HolmanChairman, Expanesthetics, Inc.

- Dr Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Limited (ASX:CYP)

11.15am - 11.45am Morning tea and networking opportunity

11.45am - 12.15pm

KEYNOTE: Australian Life Science companies raising capital and forming partnerships in the Greater China Region

Mr Rani Jarkas, Chairman, Cedrus Investments Hong Kong

12.15pm - 1.00pm

Company Spotlight Presentations

John Martin, Chief Executive Officer, Regeneus (ASX:RGS)

Steven Lydeamore, Chief Financial Officer, Bionomics Limited (ASX:BNO)

- Robert Proulx, Chief Executive Officer, Imagion Biosystems (ASX:IBX)

- Assoc Professor Derek Richard, CARP Pharmaceuticals

1.00pm - 2.00pm

Lunch and networking opportunity

2.00pm - 2.30pm

Company Spotlight Presentations

- Dr Ryan Parlett, Director Business Management Pharma Services, Patheon Biologics Australia

Megan Ford, Senior Director Research & Development, IQVIA

- Rob Scott, Director, ChinaBlueSky Partners on behalf of OncoSil Medical ASX:OSL)

2.30pm - 2.45pm

KEYNOTE: Australian healthcare investment environment and support from Austrade

Sam Guthrie, Senior Trade Commissioner, Australian Trade and Investment Commission

2.45pm - 3.00pm

PRESENTATION: The growth opportunity for life sciences in Australia

Glenn Cross, Chief Executive Officer, AusBiotech

PRESENTATION: Clinical Trials in Australia

Sue MacLeman, Managing Director and Chief Executive Officer, MTPConnect (MedTech and Pharma Growth Centre-MTP-IIGC Ltd), Australia

3.00pm - 4.30pm

Networking Reception

Venue: KPMG Hong Kong